English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Even with the best therapies, ST-elevation myocardial infarction (STEMI) is still associated with a high risk for complications, including mortality, sometimes in middle age. When a patient suffers acute STEMI, action must be taken rapidly to save myocardium, and in parallel, it is important to perform early risk stratification to predict complications and to determine prognosis. Risk assessment in acute myocardial infarction (MI) has long been an urgent concern of attending physicians. The first classification was the simple clinical Killip class, followed by the hemodynamic Forrester classification. A series of single risk factors then emerged: high-sensitivity C-reactive protein, red blood cell distribution width, hemoglobin level, central obesity, homocysteine levels, and others, each of which was shown by different individual studies to influence or modulate prognosis after MI. A more complete and comprehensive assessment, including clinical variables like age, low weight, late intervention and diabetes, and hemodynamic variables such as low blood

Is the monocyte to high-density lipoprotein cholesterol ratio important in risk stratification after myocardial infarction?